Aging Aging

130 Barnett and Ioannidesusing immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther.256, 1189–1191.16. Schmucker, D. L. (1985) Aging and drug disposition in the elderly: an update.Pharmacol. Rev. 37, 133–148.17. Durnas, C., Loi, C.-M., and Cusack, B. J. (1990) Hepatic drug metabolism andaging. Clin. Pharmacokinet. 19, 359–389.18. Wynne, H. A., Mutch, E., James, O. F. W., Rawlins, M. D., and Woodhouse, K. W.(1988) The effect of age upon the affinity of microsomal monooxygenase enzymesfor substrate in human liver. Age Ageing 17, 401–405.19. Imaoka, S., Fujita, S., and Funae, Y. (1991) Age-dependent expression ofcytochromes P-450s in rat liver. Biochim. Biophys. Acta 1097, 187–192.20. Hunt, C. M., Westerkam, W. R., Stave, G. M., and Wilson, J. A. P. (1992) Hepaticcytochrome P-4503A (CYP3A) activity in the elderly. Mech. Ageing Dev. 64,189–499.21. Hunt, C. M., Strater, S., and Stave, G. M. (1990) Effect of normal aging onthe activity of human hepatic cytochrome P-450IIE1. Biochem. Pharmacol. 40,1666–1669.22. Sotaniemi, E. A., Rautio, A., Lumme, P., Arvela, P., and Rautio, A. (1996) Age andCYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarinin man. Therapie 51, 363–366.23. Sotaniemi, E. A., Arranto, A. J., Pelkonen, O., and Pasanen, M. (1997) Age andcytochrome P450-linked drug metabolism in humans: an analysis of 226 subjectswith equal histopathologic conditions. Clin. Pharmacol. Ther. 61, 331–339.24. Burke, M. D. and Mayer, R. T. (1974) Ethoxyresorufin: Direct fluorometric assayof microsomal O-dealkylation which is preferentially induced by 3-methylcholanthrene.Drug Metab. Disp. 2, 583–588.25. Rodrigues, A. D. and Prough, R. A. (1991) Induction of cytochromes P450IA1and P450IA2 and measurement of catalytic activities. Methods Enzymol. 206,423–431.26. Ioannides, C. and Parke, D. V. (1975) Mechanism of induction of hepatic microsomaldrug metabolising enzymes by a series of barbiturates. J. Pharm. Pharmacol.27, 739–746.